Department of Gastroenterology and Hepatology, Kansas City University of Medicine and Biosciences, Kansas, USA
Mini Review
Referral of Intermediate and High-Risk Non-Alcoholic Fatty Liver Disease Patients to Hepatology Based on Noninvasive Tests
Author(s): Sarina Ailawadi and Winston Dunn*
Metabolic-Associated Fatty Liver Disease (MAFLD) is the most common liver disease that affects a quarter of the
global population. The disease naming was changed from Nonalcoholic Fatty Liver Disease (NAFLD) to MAFLD
because it positively identifies the association with etiology. The disease spectrum includes patients with and without
steatohepatitis (AKA Nonalcoholic Steatohepatitis or NASH), as well as with and without significant fibrosis (i.e. stage
2, F2). The prevalence of MAFLD is projected to increase in the coming years due to the increasing prevalence of
obesity, diabesity, and metabolic syndrome. .. View more»